RT Journal Article SR Electronic T1 Cost-Sharing in Medical Care Can Increase Adult Mortality Risk in Lower-Income Countries JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.03.03.21252857 DO 10.1101/2021.03.03.21252857 A1 Giancarlo Buitrago A1 Grant Miller A1 Marcos Vera-Hernández YR 2021 UL http://medrxiv.org/content/early/2021/03/18/2021.03.03.21252857.abstract AB Patient cost-sharing in medical care constrains total health spending, presumably with little harm to underlying patient health. This paper re-evaluates the link between cost-sharing and health, studying Colombia’s entire formal sector workforce with individual-level health care utilization records linked to payroll data and vital statistics. Given discrete breaks in outpatient cost-sharing imposed at multiple income thresholds by Colombia’s national health system, we use a regression discontinuity design and find that outpatient cost-sharing reduces use of outpatient care, resulting in fewer diagnoses of common chronic diseases and increasing subsequent emergency room visits and hospitalizations. Ultimately, these effects measurably increase mortality, and disproportionately so among the poor – raising the absolute difference in 7-year mortality risk by 0.80 and 0.23 deaths per 1,000 individuals at lower- and higher-income thresholds, respectively. To the best of our knowledge, this study is the first to show a relationship between cost-sharing and adult mortality risk in lower-income countries, a relationship important to incorporate into social welfare analyses of cost-sharing policies.One Sentence Summary Outpatient cost-sharing in medical care discourages use – but over time, also increases costly hospital service use and raises mortality risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge financial support from the UK Medical Research Council grant MR/T022175/1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our study was granted IRB ethical approval by the Research and Institutional Ethics Committee of the School of Medicine at the Universidad Nacional de Colombia (Act No. 002-015 at Feb 14/2020) and the UCL Research Ethics Committee (Notification of Ethics Approval at Sep 29/2020)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data were provided by the Ministry of Health and Social Protection of Colombia to the National University of Colombia. To access these data, requests should be submitted to the Ministry of Health and Social Protection of Colombia.